Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Aug 16, 2024

SELL
$67.36 - $77.59 $7,679 - $8,845
-114 Closed
0 $0
Q4 2023

Aug 16, 2024

SELL
$64.27 - $69.9 $12,854 - $13,980
-200 Reduced 63.69%
114 $7.93 Million
Q3 2023

Aug 16, 2024

BUY
$61.9 - $72.77 $18,570 - $21,831
300 Added 2142.86%
314 $21 Million
Q2 2023

Aug 16, 2024

SELL
$53.34 - $63.11 $130,949 - $154,935
-2,455 Reduced 99.43%
14 $884,000
Q1 2023

Aug 16, 2024

BUY
$51.63 - $56.93 $127,474 - $140,560
2,469 New
2,469 $141 Million

Others Institutions Holding RDY

About DR REDDYS LABORATORIES LTD


  • Ticker RDY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 166,028,992
  • Market Cap $13B
  • Description
  • Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...
More about RDY
Track This Portfolio

Track Td Private Client Wealth LLC Portfolio

Follow Td Private Client Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Private Client Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Td Private Client Wealth LLC with notifications on news.